Srilatha Edupuganti
7PUBLICATIONS
199CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 25, 2026
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost.Noemia S Lima, Lauren McCormick, Samuel Li
|Sep 03, 2025
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins.Sanjeev Kumar, Shilpi Jain, Bushra Wali
|May 15, 2025
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.Jordan R Willis, Madhu Prabhakaran, Michelle Muthui
|Sep 05, 2024
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.William O Hahn, K Rachael Parks, Mingchao Shen
|Aug 14, 2020
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.Prabhu S Arunachalam, Florian Wimmers, Chris Ka Pun Mok
|Jun 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi
Pageof 2
Frequent Collaborators
3 joint publications
Nadine Rouphael
2 joint publications
Peter D Kwong
2 joint publications
Michael Duff
2 joint publications
Mehul S Suthar
2 joint publications
Kellie MacPhee
2 joint publications
Eric Ortlund
2 joint publications
Gabriel Ozorowski
2 joint publications
Jens Wrammert
2 joint publications
I-Ting Teng
2 joint publications
Christina A Rostad
